Search results
Results from the WOW.Com Content Network
In clinical trials, participants with type 2 diabetes taking empagliflozin with other diabetic medications lost an average of 2% of their baseline body weight. [55] [56] A higher percentage of people taking empagliflozin achieved weight loss greater than 5% from their baseline, which has been associated with improved glucose control.
Taking medications like blood pressure and lipid-lowering drugs for more than 5 years is associated with a lower incidence of dementia, a new study has found. ... The study analyzed data from over ...
Getting diagnosed with type 2 diabetes before the age of 50 may increase one's risk of developing dementia by 1.9 times, a new study has found.
People also may not remember where their home is or the loved ones who take care of them, Dr. Kobylarz says. “You can see [the person with dementia] change at a certain time of the day and ...
In the sugar analogues of dapagliflozin, the β-C series are more active than α-C series so it is critical that the β-configuration is at C-1 for the inhibitory activity. [55] Both dapagliflozin and empagliflozin contain a chlorine (Cl) atom in their chemical structure. Cl is a halogen and it has a high electronegativity. This ...
Cardiovascular risk screening refers to the process of assessing an individual's likelihood of developing cardiovascular diseases.The main aim of screening is to identify risk factors early and adopt preventive measures to reduce morbidity and mortality.
In a statement on Friday, the two partners said Jardiance cut the risk of kidney disease progression and cardiovascular death by 28%, citing results from a late-stage trial which included people ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!